- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 5.60 Å
- Oligo State
- hetero-18-1-1-1-1-1-1-mer
- Ligands
- 19 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 38 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.20: 4 residues within 4Å:- Chain A: T.211, N.256, D.355, K.357
Ligand excluded by PLIPNAG.21: 6 residues within 4Å:- Chain A: N.213, F.214, N.215, S.252, Y.253
- Chain Q: N.380
Ligand excluded by PLIPNAG.22: 4 residues within 4Å:- Chain B: T.211, N.256, D.355, K.357
Ligand excluded by PLIPNAG.23: 6 residues within 4Å:- Chain A: N.380
- Chain B: N.213, F.214, N.215, S.252, Y.253
Ligand excluded by PLIPNAG.24: 6 residues within 4Å:- Chain C: E.209, T.211, N.256, T.258, D.355, K.357
Ligand excluded by PLIPNAG.25: 6 residues within 4Å:- Chain B: N.380
- Chain C: N.213, F.214, N.215, S.252, Y.253
Ligand excluded by PLIPNAG.26: 4 residues within 4Å:- Chain D: T.211, N.256, D.355, K.357
Ligand excluded by PLIPNAG.27: 6 residues within 4Å:- Chain C: N.380
- Chain D: N.213, F.214, N.215, S.252, Y.253
Ligand excluded by PLIPNAG.28: 4 residues within 4Å:- Chain E: E.209, N.256, D.355, K.357
Ligand excluded by PLIPNAG.29: 6 residues within 4Å:- Chain D: N.380
- Chain E: N.213, F.214, N.215, S.252, Y.253
Ligand excluded by PLIPNAG.30: 4 residues within 4Å:- Chain F: E.209, N.256, D.355, K.357
Ligand excluded by PLIPNAG.31: 7 residues within 4Å:- Chain E: H.363, N.380
- Chain F: N.213, F.214, N.215, S.252, Y.253
Ligand excluded by PLIPNAG.32: 5 residues within 4Å:- Chain G: E.209, N.256, T.258, D.355, K.357
Ligand excluded by PLIPNAG.33: 7 residues within 4Å:- Chain F: H.363, N.380
- Chain G: N.213, F.214, N.215, S.252, Y.253
Ligand excluded by PLIPNAG.34: 5 residues within 4Å:- Chain H: E.209, N.256, T.258, D.355, K.357
Ligand excluded by PLIPNAG.35: 6 residues within 4Å:- Chain G: H.363, N.380, D.382
- Chain H: N.213, N.215, Y.253
Ligand excluded by PLIPNAG.36: 5 residues within 4Å:- Chain I: E.209, T.211, N.256, T.258, K.357
Ligand excluded by PLIPNAG.37: 4 residues within 4Å:- Chain H: N.380
- Chain I: N.213, N.215, Y.253
Ligand excluded by PLIPNAG.38: 4 residues within 4Å:- Chain J: T.211, N.256, D.355, K.357
Ligand excluded by PLIPNAG.39: 5 residues within 4Å:- Chain I: H.363, N.380
- Chain J: N.213, N.215, Y.253
Ligand excluded by PLIPNAG.40: 4 residues within 4Å:- Chain K: T.211, N.256, D.355, K.357
Ligand excluded by PLIPNAG.41: 5 residues within 4Å:- Chain J: H.363, N.380
- Chain K: N.213, N.215, Y.253
Ligand excluded by PLIPNAG.42: 5 residues within 4Å:- Chain L: E.209, T.211, N.256, T.258, K.357
Ligand excluded by PLIPNAG.43: 5 residues within 4Å:- Chain K: N.380
- Chain L: N.213, F.214, N.215, Y.253
Ligand excluded by PLIPNAG.44: 4 residues within 4Å:- Chain M: T.211, N.256, D.355, K.357
Ligand excluded by PLIPNAG.45: 4 residues within 4Å:- Chain M: N.213, N.215, Y.253
- Chain R: N.380
Ligand excluded by PLIPNAG.46: 4 residues within 4Å:- Chain N: T.211, N.256, D.355, K.357
Ligand excluded by PLIPNAG.47: 4 residues within 4Å:- Chain M: N.380
- Chain N: N.213, N.215, Y.253
Ligand excluded by PLIPNAG.48: 4 residues within 4Å:- Chain O: T.211, N.256, D.355, K.357
Ligand excluded by PLIPNAG.49: 4 residues within 4Å:- Chain N: N.380
- Chain O: N.213, N.215, Y.253
Ligand excluded by PLIPNAG.50: 5 residues within 4Å:- Chain P: E.209, T.211, N.256, D.355, K.357
Ligand excluded by PLIPNAG.51: 5 residues within 4Å:- Chain O: H.363, N.380
- Chain P: N.213, N.215, Y.253
Ligand excluded by PLIPNAG.52: 4 residues within 4Å:- Chain Q: T.211, N.256, D.355, K.357
Ligand excluded by PLIPNAG.53: 6 residues within 4Å:- Chain P: N.380
- Chain Q: N.213, F.214, N.215, S.252, Y.253
Ligand excluded by PLIPNAG.54: 5 residues within 4Å:- Chain R: T.211, N.256, T.258, D.355, K.357
Ligand excluded by PLIPNAG.55: 5 residues within 4Å:- Chain R: N.213, F.214, N.215, Y.253
- Chain W: D.367
Ligand excluded by PLIPNAG.56: 4 residues within 4Å:- Chain U: N.180, K.222, K.224
- Chain X: I.413
Ligand excluded by PLIPNAG.57: 5 residues within 4Å:- Chain X: E.221, K.300, N.303, G.348, S.349
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Menny, A. et al., CryoEM reveals how the complement membrane attack complex ruptures lipid bilayers. Nat Commun (2018)
- Release Date
- 2018-12-19
- Peptides
- Complement component C9: ABCDEFGHIJKLMNOPQR
Complement C5,Complement C5: S
Complement component C8 beta chain: T
Complement component C7: U
Complement component C8 gamma chain: V
Complement component C8 alpha chain: W
Complement component C6: X - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
LB
MC
ND
OE
QF
RG
SH
TI
UJ
VK
WL
XM
PN
HO
IP
JQ
KR
GS
AT
CU
DV
EW
FX
B
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 5.60 Å
- Oligo State
- hetero-18-1-1-1-1-1-1-mer
- Ligands
- 19 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 38 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Menny, A. et al., CryoEM reveals how the complement membrane attack complex ruptures lipid bilayers. Nat Commun (2018)
- Release Date
- 2018-12-19
- Peptides
- Complement component C9: ABCDEFGHIJKLMNOPQR
Complement C5,Complement C5: S
Complement component C8 beta chain: T
Complement component C7: U
Complement component C8 gamma chain: V
Complement component C8 alpha chain: W
Complement component C6: X - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
LB
MC
ND
OE
QF
RG
SH
TI
UJ
VK
WL
XM
PN
HO
IP
JQ
KR
GS
AT
CU
DV
EW
FX
B